291 related articles for article (PubMed ID: 25644509)
1. Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma.
Andresen K; Boberg KM; Vedeld HM; Honne H; Jebsen P; Hektoen M; Wadsworth CA; Clausen OP; Lundin KE; Paulsen V; Foss A; Mathisen Ø; Aabakken L; Schrumpf E; Lothe RA; Lind GE
Hepatology; 2015 May; 61(5):1651-9. PubMed ID: 25644509
[TBL] [Abstract][Full Text] [Related]
2. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.
Vedeld HM; Andresen K; Eilertsen IA; Nesbakken A; Seruca R; Gladhaug IP; Thiis-Evensen E; Rognum TO; Boberg KM; Lind GE
Int J Cancer; 2015 Feb; 136(4):844-53. PubMed ID: 24948044
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
[TBL] [Abstract][Full Text] [Related]
4. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
5. Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer.
Feldmann G; Nattermann J; Nischalke HD; Gorschlüter M; Kuntzen T; Ahlenstiel G; Gerhardt T; Wolff M; Sauerbruch T; Spengler U; Dumoulin FL
Endoscopy; 2006 Jun; 38(6):604-9. PubMed ID: 16673309
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
[TBL] [Abstract][Full Text] [Related]
7. Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile.
Vedeld HM; Grimsrud MM; Andresen K; Pharo HD; von Seth E; Karlsen TH; Honne H; Paulsen V; Färkkilä MA; Bergquist A; Jeanmougin M; Aabakken L; Boberg KM; Folseraas T; Lind GE
Hepatology; 2022 Jan; 75(1):59-73. PubMed ID: 34435693
[TBL] [Abstract][Full Text] [Related]
8. Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.
Andresen K; Boberg KM; Vedeld HM; Honne H; Hektoen M; Wadsworth CA; Clausen OP; Karlsen TH; Foss A; Mathisen O; Schrumpf E; Lothe RA; Lind GE
Epigenetics; 2012 Nov; 7(11):1249-57. PubMed ID: 22983262
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic power of DNA methylation markers suggestive of cholangiocarcinoma in ERCP-based brush cytology.
Prachayakul V; Rugivarodom M; Nopjaroonsri P; Cheirsilpa K; Chang A; Kamolhan T; Boonyaarunnate T; Thuwajit C; Thuwajit P
Gastrointest Endosc; 2022 Jan; 95(1):123-130.e1. PubMed ID: 34265285
[TBL] [Abstract][Full Text] [Related]
10. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation in the carcinogenesis of cholangiocarcinoma.
Chiang NJ; Shan YS; Hung WC; Chen LT
Int J Biochem Cell Biol; 2015 Oct; 67():110-4. PubMed ID: 26100596
[TBL] [Abstract][Full Text] [Related]
12. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing mutation analysis on biliary brush cytology for differentiation of benign and malignant strictures in primary sclerosing cholangitis.
Kamp EJCA; Dinjens WNM; van Velthuysen MF; de Jonge PJF; Bruno MJ; Peppelenbosch MP; de Vries AC
Gastrointest Endosc; 2023 Mar; 97(3):456-465.e6. PubMed ID: 36252869
[TBL] [Abstract][Full Text] [Related]
15. The pathways of genetic transformation in cholangiocarcinogenesis.
Serafini FM; Radvinsky D
Cancer Genet; 2016 Dec; 209(12):554-558. PubMed ID: 27720541
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
17. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.
Trikudanathan G; Navaneethan U; Njei B; Vargo JJ; Parsi MA
Gastrointest Endosc; 2014 May; 79(5):783-9. PubMed ID: 24140129
[TBL] [Abstract][Full Text] [Related]
19. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.
Wasenang W; Chaiyarit P; Proungvitaya S; Limpaiboon T
Clin Epigenetics; 2019 Mar; 11(1):39. PubMed ID: 30832707
[TBL] [Abstract][Full Text] [Related]
20. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]